These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24369279)

  • 1. [Current advances and issues in selective estrogen receptor modulator (SERM) treatment].
    Ohta H
    Clin Calcium; 2014 Jan; 24(1):45-52. PubMed ID: 24369279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective estrogen receptor modulators: A possible new treatment of osteoporosis in males.
    Kastelan D; Giljevic Z; Kraljevic I; Korsic M
    Med Hypotheses; 2006; 67(5):1052-3. PubMed ID: 16790322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SERMs and SERMs with estrogen for postmenopausal osteoporosis.
    Bolognese MA
    Rev Endocr Metab Disord; 2010 Dec; 11(4):253-9. PubMed ID: 20446043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of bazedoxifene, a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis.
    Palacios S
    Curr Med Res Opin; 2010 Jul; 26(7):1553-63. PubMed ID: 20429824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Risk of Venous Thromboembolism in Bisphosphonates and Selective Estrogen Receptor Modulators Treatment in Korea.
    Park SY; Kim SH; Kim TY; Lee YK; Ha YC; Jang S; Ahn SH; Kim HY
    J Korean Med Sci; 2021 Jul; 36(27):e186. PubMed ID: 34254473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of SERMs on bone health. Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis].
    Ohta H
    Clin Calcium; 2010 Mar; 20(3):315-21. PubMed ID: 20190360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-osteoporosis drugs : their characteristics and evidence for anti-fracture efficacy].
    Takeuchi Y
    Clin Calcium; 2012 Jun; 22(6):897-903. PubMed ID: 22653031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Present development of new drugs for osteoporosis].
    Wada S
    Clin Calcium; 2006 Jan; 16(1):176-81. PubMed ID: 16397369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMs and estrogen (+/-progestogen) treatments.
    Kloosterboer HJ; Ederveen AG
    J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):157-65. PubMed ID: 12650712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estrogen, SERM].
    Hayashi T
    Nihon Rinsho; 2011 Jul; 69(7):1270-4. PubMed ID: 21774370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.
    Palacios S; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S
    Maturitas; 2012 Feb; 71(2):194-8. PubMed ID: 22176952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selective estrogen receptor modulators in treatment of postmenopausal osteoporosis].
    Meczekalski B; Czyzyk A
    Ginekol Pol; 2009 Mar; 80(3):213-7. PubMed ID: 19382614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Next generation selective estrogen receptor modulators].
    Chaki O
    Clin Calcium; 2006 Jan; 16(1):145-52. PubMed ID: 16397365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of SERMs on bone health. Changes in bone metabolism in cases of gender identity disorder].
    Miyajima T
    Clin Calcium; 2010 Mar; 20(3):380-7. PubMed ID: 20190368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective estrogen receptor modulators: the future in menopausal treatment.
    Palacios S
    Minerva Ginecol; 2011 Jun; 63(3):275-86. PubMed ID: 21654612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evidence for the selective estrogen receptor modulator raloxifene--its pharmacological characteristics, efficacy and safety profiles].
    Ohta H
    Nihon Rinsho; 2009 May; 67(5):960-6. PubMed ID: 19432117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on bazedoxifene: a novel selective estrogen receptor modulator.
    Biskobing DM
    Clin Interv Aging; 2007; 2(3):299-303. PubMed ID: 18044180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bazedoxifene: a third-generation selective estrogen receptor modulator for treatment of postmenopausal osteoporosis.
    Stump AL; Kelley KW; Wensel TM
    Ann Pharmacother; 2007 May; 41(5):833-9. PubMed ID: 17426077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetes and osteoporosis].
    Ferrari S
    Rev Med Suisse; 2013 Jun; 9(390):1256, 1258-9. PubMed ID: 23821843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical treatment of osteoporosis].
    Inoue D; Matsumoto T
    Nihon Rinsho; 2006 Sep; 64(9):1633-8. PubMed ID: 16972671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.